Recurrent Metabolic Acidosis during High-dose Midazolam Therapy for Refractory Status Epilepticus

High-dose continuous midazolam therapy has been used successfully for control of refractory status epilepticus. However, normal anion gap (AG) metabolic acidosis, a deleterious complication of this therapy is underrecognized. Even though previously reported in an isolated case report in a pediatric...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Shalendra, Khandelwal, Ankur, Datta, Rashmi, Kaushal, Ashutosh, Singh, Gyaninder Pal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842454/
https://www.ncbi.nlm.nih.gov/pubmed/29531455
http://dx.doi.org/10.4103/ijccm.IJCCM_416_17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5842454/
https://www.ncbi.nlm.nih.gov/pubmed/29531455
http://dx.doi.org/10.4103/ijccm.IJCCM_416_17

Ejemplares similares